EMBO Molecular Medicine (Aug 2024)

The evolving genetic landscape of telomere biology disorder dyskeratosis congenita

  • Hemanth Tummala,
  • Amanda J Walne,
  • Mohsin Badat,
  • Manthan Patel,
  • Abigail M Walne,
  • Jenna Alnajar,
  • Chi Ching Chow,
  • Ibtehal Albursan,
  • Jennifer M Frost,
  • David Ballard,
  • Sally Killick,
  • Peter Szitányi,
  • Anne M Kelly,
  • Manoj Raghavan,
  • Corrina Powell,
  • Reinier Raymakers,
  • Tony Todd,
  • Elpis Mantadakis,
  • Sophia Polychronopoulou,
  • Nikolas Pontikos,
  • Tianyi Liao,
  • Pradeep Madapura,
  • Upal Hossain,
  • Tom Vulliamy,
  • Inderjeet Dokal

DOI
https://doi.org/10.1038/s44321-024-00118-x
Journal volume & issue
Vol. 16, no. 10
pp. 2560 – 2582

Abstract

Read online

Abstract Dyskeratosis congenita (DC) is a rare inherited bone marrow failure syndrome, caused by genetic mutations that principally affect telomere biology. Approximately 35% of cases remain uncharacterised at the genetic level. To explore the genetic landscape, we conducted genetic studies on a large collection of clinically diagnosed cases of DC as well as cases exhibiting features resembling DC, referred to as ‘DC-like’ (DCL). This led us to identify several novel pathogenic variants within known genetic loci and in the novel X-linked gene, POLA1. In addition, we have also identified several novel variants in POT1 and ZCCHC8 in multiple cases from different families expanding the allelic series of DC and DCL phenotypes. Functional characterisation of novel POLA1 and POT1 variants, revealed pathogenic effects on protein-protein interactions with primase, CTC1-STN1-TEN1 (CST) and shelterin subunit complexes, that are critical for telomere maintenance. ZCCHC8 variants demonstrated ZCCHC8 deficiency and signs of pervasive transcription, triggering inflammation in patients’ blood. In conclusion, our studies expand the current genetic architecture and broaden our understanding of disease mechanisms underlying DC and DCL disorders.

Keywords